Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:negative regulation of receptor-mediated endocytosis involved in cholesterol transport
go back to main search page
Accession:GO:1905601 term browser browse the term
Definition:Any process that stops, prevents or reduces the frequency, rate or extent of receptor-mediated endocytosis involved in cholesterol transport.
Synonyms:exact_synonym: down regulation of receptor-mediated endocytosis involved in cholesterol transport;   downregulation of receptor-mediated endocytosis involved in cholesterol transport
 narrow_synonym: inhibition of receptor-mediated endocytosis involved in cholesterol transport;   inhibition of receptor-mediated endocytosis of LDL
 related_synonym: down regulation of receptor-mediated endocytosis involved in intracellular cholesterol transport;   down regulation of receptor-mediated endocytosis of LDL;   down regulation of receptor-mediated endocytosis of low-density lipoprotein involved in cholesterol transport;   down regulation of receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport;   downregulation of receptor-mediated endocytosis involved in intracellular cholesterol transport;   downregulation of receptor-mediated endocytosis of LDL;   downregulation of receptor-mediated endocytosis of low-density lipoprotein involved in cholesterol transport;   downregulation of receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport;   inhibition of receptor-mediated endocytosis involved in intracellular cholesterol transport;   inhibition of receptor-mediated endocytosis of low-density lipoprotein involved in cholesterol transport;   inhibition of receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport;   negative regulation of receptor-mediated endocytosis involved in intracellular cholesterol transport;   negative regulation of receptor-mediated endocytosis of LDL;   negative regulation of receptor-mediated endocytosis of low-density lipoprotein involved in cholesterol transport;   negative regulation of receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport


show annotations for term's descendants           Sort by:
 
negative regulation of receptor-mediated endocytosis involved in cholesterol transport term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCA2 ATP binding cassette subfamily A member 2 ISO (PMID:21810484) ARUK-UCL PMID:21810484 NCBI chr 9:48,610,906...48,630,932
Ensembl chr 9:48,613,996...48,629,857
JBrowse link
G PCSK9 proprotein convertase subtilisin/kexin type 9 ISO (PMID:22848640) BHF-UCL PMID:22848640 NCBI chr 5:54,197,211...54,210,724 JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  biological_process 16187
    negative regulation of biological process 5381
      negative regulation of transport 507
        negative regulation of endocytosis 46
          negative regulation of receptor-mediated endocytosis 26
            negative regulation of receptor-mediated endocytosis involved in cholesterol transport 2
Path 2
Term Annotations click to browse term
  biological_process 16187
    localization 5957
      establishment of localization 4452
        transport 4303
          organic substance transport 2348
            lipid transport 368
              regulation of lipid transport 142
                negative regulation of lipid transport 36
                  negative regulation of sterol transport 14
                    negative regulation of cholesterol transport 14
                      negative regulation of intracellular cholesterol transport 2
                        negative regulation of receptor-mediated endocytosis involved in cholesterol transport 2
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.